000			01607nam a22002057a 4500
003			KENaKMTC
005			20240129122123.0
008			231114b ||||| |||| 00| 0 eng d
020			_a97870323857642
040			_cDLC
050			_aQH588 _b.I67 2021
100			_aBirbrair Alexander,editor
245			_aAdvances in stem cell Biology _biPSCs for Modeling Central Nervous System Disorders
250			_a1st _bvol.6
260			_aUK _bAcademic press _c2021
300			_a329p. _bill.som.colored _c 22cm
504			_a Includes index
505			_a1. In Vitro Human Stem Cell Mediated CNS Platforms: Progress and Challenges 2. Human iPSCs-Based Modeling of Alzheimer’s Disease, A Glial Perspective 3. Human iPSCs-Based Studies; A New Route Toward Modelling Autism Spectrum Disorders 4. Induced Pluripotent Stem Cells (iPSCs) as Models for Amyotrophic Lateral Sclerosis (ALS) 5. iPSCs for Modeling Schizophrenia Pathogenesis 6. Human Pluripotent Stem Cells in The Research of Fragile X Syndrome 7. Induced Pluripotent Stem Cells for Modeling of Spinal Muscular Atrophy 8. Induced Pluripotent Stem Cells for Disease Modelling of Rett Syndrome 9. iPSCs for Modeling Angelman Syndrome 10. iPSCs for Modeling of X-Linked Dystonia-Parkinsonism 11. Studying Non-Cell-Autonomous Neurodegeneration in Parkinson’s Disease with Induced Pluripotent Stem Cells 12. Induced Pluripotent Stem Cell-Based Leber Hereditary Optic Neuropathy Model 13. Investigating the Pathophysiology of Anorexia Nervosa Using Induced Pluripotent Stem Cells: Background, Current Trends, and Perspectives
942			_2lcc _cBK _xV.NGENO
999			_c32648 _d32648